STOCK TITAN

Duo Health Welcomes Raul Smith as Chief Financial Officer to Executive Leadership Team

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary
Duo Health (NYSE:DUO) appoints Raul Smith as Chief Financial Officer, bringing two decades of financial leadership to lead strategic financial operations in value-based care collaborations with local providers. Smith's experience includes senior roles at Elevance Health Inc. and Alvarez & Marsal, demonstrating his alignment with Duo Health's mission to serve patients and physician partners.
Positive
  • None.
Negative
  • None.

WASHINGTON--(BUSINESS WIRE)-- Duo Health, a new type of medical group purpose-built to care for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in value-based collaborations with local providers, announced the appointment of Raul Smith as Chief Financial Officer. Smith brings nearly two decades of financial leadership and growth-stage executive experience to the role, where he will lead Duo Health’s strategic financial operations.

(Photo: Business Wire)

(Photo: Business Wire)

Prior to joining Duo Health, Smith served in senior roles at Elevance Health Inc. (NYSE:ELV) including President of the North/East Region and Head of Finance in the Medicare East Region. As the Head of Finance, he led major financial functions in value-based care and care management programs as well as optimized strategic initiatives covering approximately 900,000 Medicare members. Smith also served as a Financial Consulting Director at Alvarez & Marsal, a business consulting firm where he managed complex financial operations of growth stage healthcare organizations.

“Raul’s experience demonstrates his diligent and strategic approach to growing healthcare business, and, as importantly, his alignment with Duo Health’s mission to serve patients and our physician partners,” shared Nathan Goldstein, Duo Health’s Co-Founder and CEO. “His addition will prove to be an invaluable asset to our executive team’s commitment to deliver best-in-class service, quality, and clinical outcomes to the communities we serve.”

“I’m honored to join the team at Duo Health that has a keen focus on sustainable growth, and the vision to make healthcare more accessible,” added Smith. “The time to fundamentally shift care for chronic kidney disease and complex patients is now, and I look forward to expanding the reach of our distinctive care delivery model.”

About Duo Health:

Duo Health (“Duo”) is a new type of medical group designed around the needs of patients with chronic kidney disease and their physicians. Duo’s unique Health Mobilization™ platform partners multidisciplinary care teams with community nephrologists and activates all the other clinicians, facilities, and community organizations necessary to treat the whole patient on their own terms. The Duo Health team is comprised of leaders in value-based health care, technology and behavioral science who share a vision for advancing health equity one relationship at a time. For more information visit duohealth.com.

Sara Hightower

partners@duohealth.com

312-402-5401

Source: Duo Health

FAQ

Who is the new Chief Financial Officer of Duo Health?

Raul Smith has been appointed as the new Chief Financial Officer of Duo Health, bringing nearly two decades of financial leadership and growth-stage executive experience to the role.

What is the focus of Duo Health's mission?

Duo Health's mission is to serve patients with chronic kidney disease and end-stage kidney disease in value-based collaborations with local providers, delivering best-in-class service, quality, and clinical outcomes to the communities they serve.

What is Raul Smith's experience prior to joining Duo Health?

Prior to joining Duo Health, Smith served in senior roles at Elevance Health Inc. and Alvarez & Marsal, demonstrating his diligent and strategic approach to growing healthcare business and his alignment with Duo Health's mission.

What is the vision of Duo Health in healthcare?

Duo Health aims to make healthcare more accessible and fundamentally shift care for chronic kidney disease and complex patients, with a focus on sustainable growth and expanding the reach of their distinctive care delivery model.

Elevance Health, Inc.

NYSE:ELV

ELV Rankings

ELV Latest News

ELV Stock Data

98.77B
231.92M
0.19%
94.15%
1.15%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
INDIANAPOLIS